Stock BVX BIVICTRIX THERAPEUTICS PLC
Add to a list
To use this feature you must be a member
Log inSign up

Revisions BiVictriX Therapeutics Plc

Equities

BVX

GB00BNXH3K91

Delayed London S.E.
Other stock markets
 03:52:38 2024-05-21 am EDT 		5-day change 1st Jan Change
10.7 GBX +7.00% Intraday chart for BiVictriX Therapeutics Plc -6.96% +1.90%
Apr. 17 Bivictrix granted FDA orphan drug status for rare cancer treatment AN
Apr. 17 BiVictriX Wins US FDA's Orphan Drug Status for Blood Cancer Treatment MT

Turnover - Change in analysts' estimates

Earnings Per Share (EPS) - Change in analysts' estimates

EBIT - Change in analysts' estimates

Dividend / Share (DPS) - Change in analysts' estimates

Cash or Net Debt - Change in analysts' estimates

Turnover

Earnings Per Share (EPS)

EBIT

Dividend / Share (DPS)

Cash or Net Debt

  1. Stock Market
  2. Equities
  3. BVX Stock
  4. Revisions BiVictriX Therapeutics Plc
-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.
BENEFIT NOW